학술논문

Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids
Document Type
article
Source
Immunity. 56(8)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Immunology
Infectious Diseases
Biotechnology
Biodefense
Immunization
Influenza
Pneumonia & Influenza
Vaccine Related
Prevention
Emerging Infectious Diseases
3.4 Vaccines
Underpinning research
Prevention of disease and conditions
and promotion of well-being
1.1 Normal biological development and functioning
Infection
Inflammatory and immune system
Good Health and Well Being
Humans
Influenza Vaccines
Antibody Formation
Antibodies
Viral
T-Lymphocytes
Antigens
Organoids
Influenza
Human
B cells
B/T cell repertoire
T cells
adaptive immunity
antibodies
human immunology
influenza
organoids
vaccine modalities
vaccines
Language
Abstract
Highly effective vaccines elicit specific, robust, and durable adaptive immune responses. To advance informed vaccine design, it is critical that we understand the cellular dynamics underlying responses to different antigen formats. Here, we sought to understand how antigen-specific B and T cells were activated and participated in adaptive immune responses within the mucosal site. Using a human tonsil organoid model, we tracked the differentiation and kinetics of the adaptive immune response to influenza vaccine and virus modalities. Each antigen format elicited distinct B and T cell responses, including differences in their magnitude, diversity, phenotype, function, and breadth. These differences culminated in substantial changes in the corresponding antibody response. A major source of antigen format-related variability was the ability to recruit naive vs. memory B and T cells to the response. These findings have important implications for vaccine design and the generation of protective immune responses in the upper respiratory tract.